🔴 Cue Biopharma is trading 6.73% down in after-hours trading as immediate catalyst remains unclear

Cue Biopharma is trading 6.73% down at $31.90 after closing at $34.20 on August 14, 2026; the immediate catalyst remains unclear.

• No confirmed company-specific announcement dated August 14 was identified; the latest release found was the August 3 CFO appointment and CUE-221 IND update.
• The decline followed a sharp regular-session advance despite only modestly weaker major indexes.
• After-hours volume information was unavailable; recheck the move for delayed news.